Solo Pace Incorporated, an emerging medical technology company, today announced the commercial release of the SoloPace FUSION(TM) Temporary Pacing System. The launch follows US Food and Drug ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates Medtronic is the first and only ...
BERLIN, Germany—Conduction-system pacing (CSP), including His-bundle and left bundle branch area pacing (LBBAP), has emerged as an alternative to biventricular pacing for patients treated with cardiac ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
Patients with indications for cardiac resynchronization therapy (CRT) have better clinical outcomes when they undergo left bundle branch area pacing (LBBAP) rather than conventional biventricular ...
Please provide your email address to receive an email when new articles are posted on . Medtronic announced its cardiac lead received an expanded indication from the FDA for left bundle branch area ...
Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates DUBLIN, Oct. 17, 2022 ...